Abstract
The field of virology is undergoing a revolution as diagnostic tests and new therapies are allowing clinicians to treat, monitor, and predict outcomes of viral diseases. The majority of these techniques, however, destroy the factory of viral production and the information inherent in the reservoir – the cell. In this chapter, we describe a technique that combines cell surface immunophenotyping (to unequivocally identify cell types) and ultrasensitive fluorescence in situ hybridization (U-FISH) for HIV-1 to detect productively infected cells. Identification of virus and host (cells) allows earlier detection of changes in viral production and viral suppression but most importantly allows clinicians to monitor response to anti-viral therapy on a cell-by-cell and tissue-by-tissue basis taking into account the fact that the human body consists of very different, distinct compartments with unique selection pressures exerted on the viral life cycle.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Patterson, B.K., Czerniewski, M.A., Pottage, J., Agnoli, M., Kessler, H., Landay, A. (1999) Monitoring HIV therapy in immune cell subsets using ultrasensitive fluorescence in situ hybridization. Lancet 353, 211–212.
Furtado, M.R., Callaway, D.S., Phair, J.P., Kunstman, K.J., Stanton, J.L., Macken, C.A., Perelson, A.S., Wolinsky, S.M. (1999) Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 340, 1614–1622
Dronda, F., Moreno, S., Moreno A., Casado, JL., Perez-Elias, M.J., and Antela, A. (2002) Long-term outcomes among antiretroviral-naïve human immunodeficiency virus-infected patients with small increases in CD4+ counts after successful virologic suppression. Clin Infect Dis 35, 1005–1009.
Kedzierska, K. and Crowe, S. (2002) The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 9, 1893–1903.
Schutten, M., van Baalen, C., Guillon, C., Huisman, R., Boers P., Sintnicolaas, K., Gruters, R., and Osterhaus, A. (2001) Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure. J Virol 75, 2706–2709.
Li, S., Juarez, J., Alali, M., Dwyer, D., Collman, R., Cunningham, A., and Naif, H. (1999) Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J Virol 73, 9741–9755.
Kulkosky, J., Nunnari, G., Otero, M., Calarota, S., Dornadula, G., Zhang, H., Malin, A., Sullivan, J., Xu, Y., DeSimone, J., Babinchak, T., Stern, J., Cavert, W., Haase, A., Pomerantz, R. (2002) Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy. J Infect Dis 186, 1403–1411
Balzarini, J., Van Herrewege, Y, and Vanham G. (2002) Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells. AIDS 16, 2159–2163.
Folks T, Benn S, Rabson A, Theodore T, Hoggan MD, Martin M, Lightfoote M, Sell K. (1985). Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A 82, 4539–4543.
Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS. (1989) Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A 86, 2365–2368.
Purvis, N. and Stelzer, G. (1998) Multi-platform, multi-site instrumentation and reagent standardization. Cytometry 33, 156–165.
Patterson, B.K., McCallister, S., Schutz, M., Siegel, J.N., Shults, K., Flener, Z., Landay, A. (2001) Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in HIV-1-infected subjects on stable HAART therapy. AIDS 15, 1635–1641.
Acknowledgements
The author would like to acknowledge and thank Keith Shults for his collaborative efforts and unyielding support in the development of these techniques.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Patterson, B.K. (2010). Simultaneous Ultrasensitive Subpopulation Staining/Hybridization In Situ (SUSHI) in HIV-1 Disease Monitoring. In: Bridger, J., Volpi, E. (eds) Fluorescence in situ Hybridization (FISH). Methods in Molecular Biology, vol 659. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-789-1_26
Download citation
DOI: https://doi.org/10.1007/978-1-60761-789-1_26
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-788-4
Online ISBN: 978-1-60761-789-1
eBook Packages: Springer Protocols